期刊文献+

经脐内镜手术诊断腹膜假性黏液瘤3例的临床体会 被引量:1

Experience in transumbilical endoscopic surgery diagnosis for 3 cases of pseudomyxoma peritonei
下载PDF
导出
摘要 回顾性分析2014年9月至2014年11月应用经脐内镜手术(transumbilical endoscopic surgery,TUES)诊断3例腹膜假性黏液瘤的资料。3例腹水患者均行TUES手术确诊为腹膜假性黏液瘤,手术均获成功,无1例转手术或腹腔镜治疗,手术用时(45±16)min,术中失血量5~10 m L,术后平均恢复时间3 d。患者随访时间9~11个月,术后各患者腹壁切口未见明显疤痕,美容效果良好,均行腹腔热疗及灌注化疗,生存率100%。TUES作为一项新型腹部无痕微创手术,凭借其创伤小、无疤痕、风险小、费用低等优点,在不明原因的腹水诊断中,有较高的临床应用价值。 Three patients of pseudomyxoma peritonei who were diagnozed by transumbilical endoscopic surgery(TUES) were reviewed retrospectively from September 2014 to November 2014. Three cases of ascites patients underwent TUES were diagnozed as pseudomyxoma peritonei. All operations were successful. No open surgery or laparoscopic surgery was required. The mean operative time was(45±16) min; the mean intraoperative blood loss was 510 m L; the mean hospital stay time was 3 days. During the follow up of 911 months, no obvious scar was observed. Cosmetic results appear to be excellent. All patients were treated with intraperitoneal hyperthermia and chemotherapy. Th e survival rate was 100%. As a novel scarless endoscopic invasive abdominal surgery, TUES has high clinical value with the advantages such as small trauma, no scars, small risk and low cost in the diagnosis of unexplained ascites.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2016年第11期1241-1244,共4页 Journal of Central South University :Medical Science
基金 国家自然科学基金(81472286)~~
关键词 TUES 腹膜黏液瘤 腹壁无痕微创手术 TUES pseudomyxoma peritonei scarless invasive abdominal surgery
  • 相关文献

参考文献3

二级参考文献34

  • 1安子元,徐大毅,安照源.腹膜活检的方法及诊断价值(附302例腹膜疾病分析)[J].中国实用内科杂志,1996,16(1):35-36. 被引量:14
  • 2[29]Bryant J,Clegg AJ,Sidhu MK,Brodin H,Royle P,Davidson P.Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei.Health Technol Assess 2004; 8:iii,1-54
  • 3[30]Gomez Portilla A,Deraco M,Sugarbaker PH.Clinical pathway for peritoneal carcinomatosis from colon and rectal cancer:guidelines for current practice.Tumori 1997; 83:725-728
  • 4[31]Deraco M,Rossi CR,Pennacchioli E,Guadagni S,Somers DC,Santoro N,Raspagliesi F,Kusamura S,Vaglini M.Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer:a phase Ⅱ clinical study.Tumori 2001; 87:120-126
  • 5[1]Werth R.Pseudomyxoma peritonei.Arch Gynaecol 1884; 24:100-118
  • 6[2]van Ruth S,Acherman YI,van de Vijver MJ,Hart AA,Verwaal VJ,Zoetmulder FA.Pseudomyxoma peritonei:a review of 62 cases.Eur J Surg Oncol 2003; 29:682-688
  • 7[3]Sugarbaker PH.Pseudomyxoma peritonei.A cancer whose biology is characterized by a redistribution phenomenon.Ann Surg 1994; 219:109-111
  • 8[4]Deraco M,Santoro N,Carraro O,Inglese MG,Rebuffoni G,Guadagni S,Somers DC,Vaglini M.Peritoneal carcinomatosis:feature of dissemination.A review.Tumori 1999; 85:1-5
  • 9[5]Moran BJ,Cecil TD.The etiology,clinical presentation,and management of pseudomyxoma peritonei.Surg Oncol Clin N Am 2003; 12:585-603
  • 10[6]Sugarbaker PH.Cytoreductive surgery and intraperitoneal chemotherapy with peritoneal spread of cystadenocarcinoma.Eur J Surg Suppl 1991; 561:75-82

共引文献20

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部